|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross margin | |||||
| Selling and administrative expenses | |||||
| Research and development expenses | |||||
| Operating (loss) income | |||||
| Other income (expense): | |||||
| Income on investments | |||||
| Interest expense | |||||
| Other expense, net | |||||
| (Loss) income before benefit from income taxes | |||||
| Benefit from income taxes | |||||
| Net (loss) income | |||||
| Change in market value of marketable securities before reclassification, net of tax | |||||
| Reclassification adjustment for realized gains included in net income, net of tax | |||||
| Total unrealized gain on marketable securities, net of tax | |||||
| Comprehensive income (loss) | |||||
| Basic and diluted earnings (loss) per share (in Dollars per share) | |||||
| Net (loss) income per common share: | |||||
| Basic (loss) income per share (in Dollars per share) | |||||
| Diluted (loss) income per share (in Dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...